NPR News: Johnson & Johnson Applies For Emergency Use Authorization for Anti-COVID-19 Vaccine

Johnson & Johnson Applies For Emergency Use Authorization for Anti-COVID-19 Vaccine
The company's vaccine has shown to be 85% effective against severe forms of the disease. Patients will only need to receive one shot instead of two, as with other vaccines already in use in the U.S.

Read more on NPR
Health & Science - February 5, 2021 at 07:44AM - Johnson & Johnson Applies For Emergency Use Authorization for Anti-COVID-19 Vaccine